22

Sen U, Tyagi N, Moshal KS, Kartha GK, Rosenberger D, Henderson BC, et al. Cardiac synchronous and dys-synchronous remodeling in diabetes mellitus. Antioxid Redox Signal 2007; 9(7):971-8. [More details]

21

Gong W, Liu ZH, Zeng CH, Peng A, Chen HP, Zhou H, Li LS. Amylin deposition in the kidney of patients with diabetic nephropathy. Kidney Int 2007; 72(2):213-8. [More details]

20

Winter R, Lopes D, Grudzielanek S, et al. Towards an understanding of the temperature/pressure configurational and free-energy landscape of biomolecules. Journal of Non-Equilibrium Thermodynamics 2007; 32(1):41-97. [More details]

19

Wright S, Malinin NL, Powell KA, Yednock T, Rydel RE, Griswold-Prenner I. Alpha2beta1 and alphaVbeta1 integrin signaling pathways mediate amyloid-beta-induced neurotoxicity. Neurobiol Aging 2007; 28(2):226-37. [More details]

18

Hayden MR, Sowers JR. Hypertension in type 2 diabetes mellitus. Insulin 2006; 1(1):22-37. [More details]

17

Stadler M, Anderwald C, Karer T, Tura A, Kastenbauer T, Auinger M, et al. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?. Diabetes Care 2006; 29(5):1031-8. [More details]

16

Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR. Type 2 Diabetes Mellitus as a Conformational Disease. JOP. J Pancreas (Online) 2005; 6(4):287-302. [More details]

15

Tyagi SC, Rodriguez W, Patel AM, Roberts AM, Falcone JC, Passmore JC, et al. Hyperhomocysteinemic diabetic cardiomyopathy: oxidative stress, remodeling, and endothelial-myocyte uncoupling. J Cardiovasc Pharmacol Ther 2005; 10(1):1-10. [More details]

14

Hayden MR, Tyagi SC. Neural redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic neuropathy. Med Sci Monit 2004; 10(12):RA291-307. [More details]

13

Nicolls MR. The clinical and biological relationship between type II diabetes mellitus and Alzheimer’s disease. Curr Alzheimer Res 2004; 1(1):47-54. [More details]

12

Waine C. The Metabolic Syndrome. The National Obesity Forum E-book. [More details]

11

Lopes DHJ, Colin C, Degaki TL, de Sousa AC, Vieira MN, Sebollela A, et al. Amyloidogenicity and Cytotoxicity of Recombinant Mature Human Islet Amyloid Polypeptide (rhIAPP). J Biol Chem 2004; 279(41):42803-10. [More details]

10

Dealwis C, Wall J. Towards understanding the structure-function relationship of human amyloid disease. Curr Drug Targets 2004; 5(2):159-71. [More details]

9

Hayden MR, Tyagi SC. Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure. Med Sci Monit 2003; 9(7):SR35-52. [More details]

8

Tyagi SC, Hayden MR. Role of nitric oxide in matrix remodeling in diabetes and heart failure. Heart Fail Rev 2003; 8(1):23-8. [More details]

7

Conway KA, Baxter EW, Felsenstein KM, Reitz AB. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease. Curr Pharm Des 2003; 9(6):427-47. [More details]

6

Camp TM, Tyagi SC, Senior RM, Hayden MR, Tyagi SC. Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice. Diabetologia 2003; 46(10):1438-45. [More details]

5

Ong SG, Harrow C, Devgun MS, Field M. Cryofibrinogenaemia complicated by amyloidosis: a new association. Rheumatology (Oxford) 2003; 42(6):797-8. [More details]

4

Nicolls MR, D'Antonio JM, Hutton JC, Gill RG, Czwornog JL, Duncan MW. Proteomics as a tool for discovery: proteins implicated in Alzheimer's disease are highly expressed in normal pancreatic islets. J Proteome Res 2003; 2(2):199-205. [More details]

3

Hayden MR, Tyagi SC. Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovasc Diabetol 2002; 1(1):3. [More details]

2

Hayden MR. Islet Amyloid, Metabolic Syndrome, and the Natural Progressive History of Type 2 Diabetes Mellitus. JOP. J Pancreas (Online) 2002; 3(5):126-138. [More details]

1

Hayden MR, Tyagi SC. Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus. JOP. J Pancreas (Online) 2002; 3(4):86-108. [More details]